Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative-Intent Surgery for Intrahepatic Cholangiocarcinoma.
anemia
blood transfusion
cholangiocarcinoma
liver resection
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
16 Sep 2024
16 Sep 2024
Historique:
received:
24
08
2024
accepted:
30
08
2024
medline:
17
9
2024
pubmed:
17
9
2024
entrez:
17
9
2024
Statut:
aheadofprint
Résumé
Among patients undergoing liver resection for intrahepatic cholangiocarcinoma (ICC), perioperative bleeding requiring blood transfusion is a common complication, yet preoperative identification of patients at risk for transfusion remains challenging. The objective of this study was to develop a preoperative risk score for blood transfusion requirement during surgery for ICC. Patients undergoing curative-intent liver surgery for ICC (1990-2020) were identified from a multi-institutional database. A predictive model was developed and validated. An easy-to-use risk calculator was made available online. Among 1420 patients, 300 (21.1%) received an intraoperative transfusion. Independent predictors of transfusion included severe preoperative anemia (OR = 1.65, 95% CI 1.10-2.47), T2 category or higher (OR = 2.00, 95% CI 1.36-3.02), positive lymph nodes (OR = 1.75, 95% CI 1.32-2.32) and major resection (OR = 2.56, 95%CI 1.85-3.58). Receipt of blood transfusion significantly correlated with worse outcomes. The model showed good discriminative ability in both training (AUC = 0.68, 95% CI 0.66-0.72) and bootstrapping validation (C-index = 0.67, 95% CI 0.65-0.70) cohorts. An online risk calculator of blood transfusion requirement was developed (https://catalano-giovanni.shinyapps.io/TransfusionRisk). Intraoperative blood transfusion was significantly associated with poor postoperative outcomes among patients undergoing surgery for ICC. The identification of patients at high risk of transfusion could improve perioperative patient care and blood resources allocation.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Among patients undergoing liver resection for intrahepatic cholangiocarcinoma (ICC), perioperative bleeding requiring blood transfusion is a common complication, yet preoperative identification of patients at risk for transfusion remains challenging. The objective of this study was to develop a preoperative risk score for blood transfusion requirement during surgery for ICC.
METHODS
METHODS
Patients undergoing curative-intent liver surgery for ICC (1990-2020) were identified from a multi-institutional database. A predictive model was developed and validated. An easy-to-use risk calculator was made available online.
RESULTS
RESULTS
Among 1420 patients, 300 (21.1%) received an intraoperative transfusion. Independent predictors of transfusion included severe preoperative anemia (OR = 1.65, 95% CI 1.10-2.47), T2 category or higher (OR = 2.00, 95% CI 1.36-3.02), positive lymph nodes (OR = 1.75, 95% CI 1.32-2.32) and major resection (OR = 2.56, 95%CI 1.85-3.58). Receipt of blood transfusion significantly correlated with worse outcomes. The model showed good discriminative ability in both training (AUC = 0.68, 95% CI 0.66-0.72) and bootstrapping validation (C-index = 0.67, 95% CI 0.65-0.70) cohorts. An online risk calculator of blood transfusion requirement was developed (https://catalano-giovanni.shinyapps.io/TransfusionRisk).
CONCLUSIONS
CONCLUSIONS
Intraoperative blood transfusion was significantly associated with poor postoperative outcomes among patients undergoing surgery for ICC. The identification of patients at high risk of transfusion could improve perioperative patient care and blood resources allocation.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : The authors received no specific funding for this work.
Informations de copyright
© 2024 The Author(s). Journal of Surgical Oncology published by Wiley Periodicals LLC.
Références
A. K. Singal, J.‐N. Vauthey, J. J. Grady, and J. R. Stroehlein, “Intra‐Hepatic Cholangiocarcinoma—Frequency and Demographic Patterns: Thirty‐Year Data From the M.D. Anderson Cancer Center,” Journal of Cancer Research and Clinical Oncology 137 (2011): 1071–1078.
A. B. Benson, M. I. D'Angelica, D. E. Abbott, et al., “Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology,” Journal of the National Comprehensive Cancer Network 19 (2021): 541–565.
P. J. Kneuertz, H. A. Pitt, K. Y. Bilimoria, et al., “Risk of Morbidity and Mortality Following Hepato‐Pancreato‐Biliary Surgery,” Journal of Gastrointestinal Surgery 16 (2012): 1727–1735.
A. J. Kansagra and M. S. Stefan, “Preoperative Anemia,” Anesthesiology Clinics 34 (2016): 127–141.
M. N. Mavros, L. Xu, H. Maqsood, et al., “Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta‐Analysis,” Annals of Surgical Oncology 22 (2015): 4382–4391.
A. G. Acheson, M. J. Brookes, and D. R. Spahn, “Effects of Allogeneic Red Blood Cell Transfusions on Clinical Outcomes in Patients Undergoing Colorectal Cancer Surgery: A Systematic Review and Meta‐Analysis,” Annals of Surgery 256 (2012): 235–244.
A. Amato and M. Pescatori, “Perioperative Blood Transfusions and Recurrence of Colorectal Cancer,” Cochrane Database Systematic Review 2011, no. 1 (2006): CD005033, https://doi.org/10.1002/14651858.CD005033.pub2.
C. Sun, Y. Wang, H. S. Yao, and Z. Q. Hu, “Allogeneic Blood Transfusion and the Prognosis of Gastric Cancer Patients: Systematic Review and Meta‐Analysis,” International Journal of Surgery 13 (2015): 102–110.
N. Amini, G. Spolverato, Y. Kim, and T. M. Pawlik, “Trends in Hospital Volume and Failure to Rescue for Pancreatic Surgery,” Journal of Gastrointestinal Surgery 19 (2015): 1581–1592.
S. A. Ahmad, M. J. Edwards, J. M. Sutton, et al., “Factors Influencing Readmission After Pancreaticoduodenectomy: A Multi‐Institutional Study of 1302 Patients,” Annals of Surgery 256 (2012): 529–537.
C. N. Clarke, J. J. Sussman, D. E. Abbott, and S. A. Ahmad, “Factors Affecting Readmission After Pancreaticoduodenectomy,” Advances in Surgery 47 (2013): 99–110.
M. F. Murphy, A. Harris, J. Neuberger, et al., “Consent for Blood Transfusion: Summary of Recommendations From the Advisory Committee for the Safety of Blood, Tissues and Organs (SaBTO),” Clinical Medicine 21 (2021): 201–203.
National Institute for Health and Care Excellence (NICE). NICE Guideline, No. 24. 20, Patient Information. Blood Transfusion. (London: National Clinical Guideline Centre (UK), 2015), https://www.ncbi.nlm.nih.gov/books/NBK338774/.
J. L. J. Chin, J. C. Allen, Y.‐X. Koh, et al., “Poor Utility of Current Nomograms Assessing the Risk of Intraoperative Blood Transfusion in Patients Undergoing Liver Resection for Hepatocellular Carcinoma and Proposal of a New Model,” Surgery 172 (2022): 1442–1447.
C. W. Kimbrough, S. C. Agle, C. R. Scoggins, et al., “Factors Predictive of Readmission After Hepatic Resection for Hepatocellular Carcinoma,” Surgery 156 (2014): 1039–1048.
C. B. C. Cunha, T. A. Lima, D. L. M. Ferraz, et al., “Predicting the Need for Blood Transfusions in Cardiac Surgery: A Comparison between Machine Learning Algorithms and Established Risk Scores in the Brazilian Population,” Brazilian Journal of Cardiovascular Surgery 39 (2024): e20230212.
J. Leff, C. A. Romano, S. Gilbert, and S. Nair, “Validation Study of the Transfusion Risk and Clinical Knowledge (TRACK) Tool in Cardiac Surgery Patients: A Retrospective Analysis,” Journal of Cardiothoracic and Vascular Anesthesia 33 (2019): 2669–2675.
S. M. Lee, G. Lee, T. K. Kim, et al., “Development and Validation of a Prediction Model for Need for Massive Transfusion During Surgery Using Intraoperative Hemodynamic Monitoring Data,” JAMA Network Open 5 (2022): e2246637.
K. Wang, H. Zhang, Y. Xia, J. Liu, and F. Shen, “Surgical Options for Intrahepatic Cholangiocarcinoma,” HepatoBiliary Surgery and Nutrition 6 (2017): 79–90.
Y. Kim, F. Bagante, F. Gani, et al., “Nomogram to Predict Perioperative Blood Transfusion for Hepatopancreaticobiliary and Colorectal Surgery,” British Journal of Surgery 103 (2016): 1173–1183.
K. Merath, J. M. Hyer, R. Mehta, et al., “Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery,” Journal of Gastrointestinal Surgery 24 (2020): 1843–1851.
L. Alaimo, Y. Endo, G. Catalano, et al., “Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma,” Annals of Surgical Oncology 31 (2024): 3043–3052, https://doi.org/10.1245/s10434-023-14880-8.
D. I. Tsilimigras, D. Moris, R. Mehta, et al., “The Systemic Immune‐Inflammation Index Predicts Prognosis in Intrahepatic Cholangiocarcinoma: An International Multi‐Institutional Analysis,” HPB 22 (2020): 1667–1674.
D. I. Tsilimigras, R. Mehta, L. Aldrighetti, et al., “Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma,” Journal of the American College of Surgeons 230 (2020): 381–391.e2.
D. I. Tsilimigras, J. M. Hyer, D. Moris, et al., “Prognostic Utility of Albumin‐Bilirubin Grade for Short‐ and Long‐Term Outcomes Following Hepatic Resection for Intrahepatic Cholangiocarcinoma: A Multi‐Institutional Analysis of 706 Patients,” Journal of Surgical Oncology 120 (2019): 206–213.
M. Domenica Cappellini and I. Motta, “Anemia in Clinical Practice—Definition and Classification: Does Hemoglobin Change With Aging?,” Seminars in Hematology 52 (2015): 261–269.
H. Y. Kwon, B. R. Kim, and Y. W. Kim, “Association of Preoperative Anemia and Perioperative Allogenic Red Blood Cell Transfusion With Oncologic Outcomes in Patients With Nonmetastatic Colorectal Cancer,” Current Oncology 26 (2019): 357–366.
T. W. Kim, H. J. Park, M. J. Chang, et al., “Effect of Severity and Cause of Preoperative Anemia on the Transfusion Rate After Total Knee Arthroplasty,” Scientific Reports 12 (2022): 4083.
M. B. Amin, F. L. Greene, S. B. Edge, et al., “The Eighth Edition Ajcc Cancer Staging Manual: Continuing to Build a Bridge From a Population‐Based to a More ‘Personalized’ Approach to Cancer Staging,” CA: A Cancer Journal for Clinicians 67 (2017): 93–99.
Y. Y. Pang and S. M. Strasberg, “The Brisbane 2000 Terminology of Liver Anatomy and Resections,” HPB 4 (2002): 99–100.
S. Van Buuren, H. C. Boshuizen, and D. L. Knook, “Multiple Imputation of Missing Blood Pressure Covariates in Survival Analysis,” Statistics in Medicine 18 (1999): 681–694.
M. N. Mavros, K. P. Economopoulos, V. G. Alexiou, and T. M. Pawlik, “Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta‐Analysis,” JAMA Surgery 149 (2014): 565.
T. A. Aloia, B. N. Fahy, C. P. Fischer, et al., “Predicting Poor Outcome Following Hepatectomy: Analysis of 2313 Hepatectomies in the NSQIP Database,” HPB 11 (2009): 510–515.
Y. Makino, A. Yamanoi, T. Kimoto, O. N. El‐Assal, H. Kohno, and N. Nagasue, “The Influence of Perioperative Blood Transfusion on Intrahepatic Recurrence After Curative Resection of Hepatocellular Carcinoma,” American Journal of Gastroenterology 95 (2000): 1294–1300.
A. Ejaz, G. Spolverato, Y. Kim, et al., “Impact of Blood Transfusions and Transfusion Practices on Long‐Term Outcome Following Hepatopancreaticobiliary Surgery,” Journal of Gastrointestinal Surgery 19 (2015): 887–896.
L. M. Postlewait, M. H. Squires, D. A. Kooby, et al., “The Relationship of Blood Transfusion With Peri‐Operative and Long‐Term Outcomes After Major Hepatectomy for Metastatic Colorectal Cancer: A Multi‐Institutional Study of 456 Patients,” HPB 18 (2016): 192–199.
N. Roberts, S. James, M. Delaney, and C. Fitzmaurice, “The Global Need and Availability of Blood Products: A Modelling Study,” The Lancet Haematology 6 (2019): e606–e615.
C. Miki, J. Hiro, E. Ojima, Y. Inoue, Y. Mohri, and M. Kusunoki, “Perioperative Allogeneic Blood Transfusion, the Related Cytokine Response and Long‐Term Survival After Potentially Curative Resection of Colorectal Cancer,” Clinical Oncology 18 (2006): 60–66.
M. Ghio, P. Contini, C. Mazzei, et al., “In Vitro Immunosuppressive Activity of Soluble Hla Class I and Fas Ligand Molecules: Do They Play a Role in Autologous Blood Transfusion?,” Transfusion 41 (2001): 988–996.
J. P. Cata, H. Wang, V. Gottumukkala, J. Reuben, and D. I. Sessler, “Inflammatory Response, Immunosuppression, and Cancer Recurrence After Perioperative Blood Transfusions,” British Journal of Anaesthesia 110 (2013): 690–701.
S. Kim, E. C. Maynard, M. B. Shah, et al., “Risk Factors for 30‐Day Readmissions After Hepatectomy: Analysis of 2444 Patients From the ACS‐NSQIP Database,” Journal of Gastrointestinal Surgery 19 (2015): 266–271.
H.‐Q. Wang, J. Yang, J.‐Y. Yang, W. T. Wang, and L. N. Yan, “Development and Validation of a Predictive Score for Perioperative Transfusion in Patients With Hepatocellular Carcinoma Undergoing Liver Resection,” Hepatobiliary & Pancreatic Diseases International 14 (2015): 394–400.
C. Pulitanò, M. Arru, L. Bellio, S. Rossini, G. Ferla, and L. Aldrighetti, “A Risk Score for Predicting Perioperative Blood Transfusion in Liver Surgery,” British Journal of Surgery 94 (2007): 860–865.
HPB CONCEPT Team, M. Lemke, C. H. L. Law, J. Li, et al., “Three‐Point Transfusion Risk Score in Hepatectomy,” British Journal of Surgery 104 (2017): 434–442.
A. J. Cockbain, T. Masudi, J. P. A. Lodge, G. J. Toogood, and K. R. Prasad, “Predictors of Blood Transfusion Requirement in Elective Liver Resection,” HPB 12 (2010): 50–55.
C. S. Sima, W. R. Jarnagin, Y. Fong, et al., “Predicting the Risk of Perioperative Transfusion for Patients Undergoing Elective Hepatectomy,” Annals of Surgery 250 (2009): 914–921.
F. Gani, M. Cerullo, A. Ejaz, et al., “Implementation of a Blood Management Program at a Tertiary Care Hospital: Effect on Transfusion Practices and Clinical Outcomes Among Patients Undergoing Surgery,” Annals of Surgery 269 (2019): 1073–1079.
A. Ejaz, S. M. Frank, G. Spolverato, M. Mavros, Y. Kim, and T. M. Pawlik, “Variation in the Use of Type and Crossmatch Blood Ordering Among Patients Undergoing Hepatic and Pancreatic Resections,” Surgery 159 (2016): 908–918.
A. Subramanian, K. Rangarajan, S. Kumar, K. Farooque, V. Sharma, and M. Misra, “Reviewing the Blood Ordering Schedule for Elective Orthopedic Surgeries at a Level One Trauma Care Center,” Journal of Emergencies, Trauma, and Shock 3 (2010): 225.
G. Niranjan, G. Asimakopoulos, A. Karagounis, G. Cockerill, M. Thompson, and V. Chandrasekaran, “Effects of Cell Saver Autologous Blood Transfusion on Blood Loss and Homologous Blood Transfusion Requirements in Patients Undergoing Cardiac Surgery On‐ Versus Off‐Cardiopulmonary Bypass: A Randomised Trial☆,” European Journal of Cardio‐Thoracic Surgery 30 (2006): 271–277.
R. L. Tawes, R. G. Scribner, T. B. Duval, et al., “The Cell‐Saver and Autologous Transfusion: An Underutilized Resource in Vascular Surgery,” The American Journal of Surgery 152 (1986): 105–109.